Transradial Neuroendovascular Treatment for Anterior Circulation Lesions: An Initial Experience with a 6 Fr Guiding Sheath

JNET Pub Date : 2018-08-09 DOI:10.5797/JNET.OA.2018-0055

Y. Hanaoka, J. Koyama, Alhusain Nagm, Toshiya Uchiyama, Takafumi Kiuchi, Keisuke Kamiya, Takaaki Kamijo, T. Ogiwara, T. Horiuchi, K. Hongo

{"title":"Transradial Neuroendovascular Treatment for Anterior Circulation Lesions: An Initial Experience with a 6 Fr Guiding Sheath","authors":"Y. Hanaoka, J. Koyama, Alhusain Nagm, Toshiya Uchiyama, Takafumi Kiuchi, Keisuke Kamiya, Takaaki Kamijo, T. Ogiwara, T. Horiuchi, K. Hongo","doi":"10.5797/JNET.OA.2018-0055","DOIUrl":null,"url":null,"abstract":"Objective: To clarify the usefulness and safety of neuroendovascular treatment with a 6 Fr guiding sheath via the right radial artery for anterior circulation lesions. Methods: A total of 20 patients (carotid artery stenting: 11 patients, coil embolization of cerebral aneurysms: nine patients) who underwent neuroendovascular treatment via the right radial artery under general anesthesia, between September 2016 and June 2017, were included in this study. We retrospectively analyzed 1) the pertinent anatomy of the target-side common carotid artery and the aortic arch, 2) devices, 3) method to advance the guiding sheath into the common carotid artery, 4) hemostasis at the puncture site, and 5) outcome (success rate, perioperative complications, and complications at the site of puncture). Results: In all patients, a 6 Fr guiding sheath could be guided into the common carotid artery, and treatment was accomplished. Furthermore, there was no perioperative or puncture-site complication. Conclusion: Transradial neuroendovascular treatment is considered as a safe and successful choice for anterior circulation lesions.","PeriodicalId":34768,"journal":{"name":"JNET","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNET","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5797/JNET.OA.2018-0055","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 5

Abstract

Objective: To clarify the usefulness and safety of neuroendovascular treatment with a 6 Fr guiding sheath via the right radial artery for anterior circulation lesions. Methods: A total of 20 patients (carotid artery stenting: 11 patients, coil embolization of cerebral aneurysms: nine patients) who underwent neuroendovascular treatment via the right radial artery under general anesthesia, between September 2016 and June 2017, were included in this study. We retrospectively analyzed 1) the pertinent anatomy of the target-side common carotid artery and the aortic arch, 2) devices, 3) method to advance the guiding sheath into the common carotid artery, 4) hemostasis at the puncture site, and 5) outcome (success rate, perioperative complications, and complications at the site of puncture). Results: In all patients, a 6 Fr guiding sheath could be guided into the common carotid artery, and treatment was accomplished. Furthermore, there was no perioperative or puncture-site complication. Conclusion: Transradial neuroendovascular treatment is considered as a safe and successful choice for anterior circulation lesions.

查看原文本刊更多论文

经桡神经血管内治疗前循环病变：6Fr导引鞘的初步经验

目的：阐明经右桡动脉使用6Fr引导鞘进行神经血管内治疗前循环病变的有效性和安全性。方法：本研究共纳入20名患者（颈动脉支架置入术：11名患者，脑动脉瘤线圈栓塞术：9名患者），他们在2016年9月至2017年6月期间在全麻下通过右桡动脉接受神经血管内治疗。我们回顾性分析了1）目标侧颈总动脉和主动脉弓的相关解剖结构，2）装置，3）将引导鞘推进颈总动脉的方法，4）穿刺部位的止血，以及5）结果（成功率、围手术期并发症和穿刺部位的并发症）。结果：在所有患者中，6Fr引导鞘可以被引导进入颈总动脉，并完成了治疗。此外，无围手术期或穿刺部位并发症。结论：经桡神经血管内治疗前循环病变是一种安全、成功的选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

JNET

自引率

0.00%

发文量

审稿时长

17 weeks

期刊介绍： JNET Journal of Neuroendovascular Therapy is the official journal of the Japanese Society for Neuroendovascular Therapy (JSNET). The JNET publishes peer-reviewed original research related to neuroendovascular therapy, including clinical studies, state-of-the-art technology, education, and basic sciences.